Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2003 Sep;80(3):455–464. doi: 10.1093/jurban/jtg052

An external evaluation of a peer-run “Unsanctioned” syringe exchange program

Evan Wood 1,2, Thomas Kerr 1,3, Patricia M Spittal 1, William Small 1, Mark W Tyndall 1,2, Michael V O’Shaughnessy 1,4, Martin T Schechter 1,5
PMCID: PMC3455981  PMID: 12930883

Abstract

In Vancouver, British Columbia, Canada, difficulty accessing syringes at night has been shown to be strongly associated with human immunodeficiency virus (HIV) risk behavior among the city’s injection drug users (IDUs). On September 1, 2001, the Vancouver Area Network of Drug Users (VANDU) initiated an unsanctioned all-night needle-exchange program on a street corner in the heart of the neigh-borbood where many of the city’s IDUs are concentrated. An external evaluation of the population reached by the VANDU exchange was performed through the Vancouver Injection Drug User’s Study, a prospective cohort study of IDUs begun in 1996. Persons accessing syringes through the exchange were compared to those active injectors who acquired their syringes from other sources, including the city’s fixed site exchange, which closes at 8:00 pm. Overall, 587 active IDUs were seen during the period September 2001 to june 2002; of these individuals. 165 (28.1%) reported using the VANDU exchange. In multivariate analyses, participants who used the VANDU table were more likely to frequently inject cocaine (adjusted odds ratio [AOR]=1.56; 95% confidence interval [CI]=1.00–2.44), inject in public (AOR=2.71; 95% CI=1.62–4.53), and require help injecting (OR=2.13; 95% CI=1.33–3.42). Interestingly, use of the table was also independently associated with safer syringe disposal (AOR=2.69; 95% CI-1.38–5.21). Results indicate that the unsanctioned exchange appears to have reached those IDUs at highest risk of HIV infection. Although the cross-sectional nature of the study design warrants caution, we also found that use of the nighttime exchange was strongly associated with higher rates of safe syringe disposal. The data suggest that drug user organizations can play a major role in reducing harm among their peers by reaching the highest risk drug users with harm reduction services. The findings also suggest that other forms of syringe-exchange programs should consider the benefits of offering fixed site nighttime service.

Keywords: Harin reduction, HIV/AIDS, Peer, Vancouver, VANDU

Full Text

The Full Text of this article is available as a PDF (80.2 KB).

References

  • 1.Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000;14:605–611. doi: 10.1097/00002030-200003310-00015. [DOI] [PubMed] [Google Scholar]
  • 2.Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–991. doi: 10.1016/S0140-6736(96)02536-6. [DOI] [PubMed] [Google Scholar]
  • 3.Heimer R, Kaplan EH, Khoshnook K, Jariwala B, Cadman EC. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med. 1993;95:214–220. doi: 10.1016/0002-9343(93)90263-O. [DOI] [PubMed] [Google Scholar]
  • 4.Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15:1329–1341. doi: 10.1097/00002030-200107270-00002. [DOI] [PubMed] [Google Scholar]
  • 5.Lurie F, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 1997;349:604–608. doi: 10.1016/S0140-6736(96)05439-6. [DOI] [PubMed] [Google Scholar]
  • 6.Taussig JA, Weinstein B, Burris S, Jones TS. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS. 2000;14:S47–S51. doi: 10.1097/00002030-200006001-00007. [DOI] [PubMed] [Google Scholar]
  • 7.bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol. 1997;18:61–83. doi: 10.1080/01459740.1997.9966150. [DOI] [PubMed] [Google Scholar]
  • 8.Bluthenthal RN, Lorvick J, Kral AH, et al. Collateral damage in the war on drugs: HIV risk behaviours among injection drug users. Int J Drug Policy. 1999;10:25–38. doi: 10.1016/S0955-3959(98)00076-0. [DOI] [Google Scholar]
  • 9.Wood E, Tyndall MW, Spittal P, et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemid. Int J Drug Policy. 2002;13:95–102. doi: 10.1016/S0955-3959(02)00008-7. [DOI] [Google Scholar]
  • 10.Strathdee SA, Patrick DM, Archibald CP, et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction. 1997;92:1339–1347. doi: 10.1111/j.1360-0443.1997.tb02852.x. [DOI] [PubMed] [Google Scholar]
  • 11.Spittal P, Small W, Laliberte N, O’Shaughnessy MV, Schechter MT. Exchange versus distribution: the challenge of managing access to clean syringes in the context of an ongoing HIV epidemic in Vancouver. Can J Infect Dis. 2002;13:78A–78A. [Google Scholar]
  • 12.Wood E, Tyndall MW, Spittal PM, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002;16:941–943. doi: 10.1097/00002030-200204120-00021. [DOI] [PubMed] [Google Scholar]
  • 13.Tyndall MW, Bruneau J, Brogly S, Spittal P, O’Shaughnessy MV, Schechter MT. Satellite needle distribution among injection drug users: policy and practice in two Canadian cities. J Acquir Immune Defic Syndr. 2002;31:98–105. doi: 10.1097/00126334-200209010-00013. [DOI] [PubMed] [Google Scholar]
  • 14.Grund JP, Blanken P, Adriaans NF, Kaplan CD, Barendregt C, Meeuwsen M. Reaching the unreached: targeting hidden IDU populations with clean needles via known user groups. J Psychoactive Drugs. 1992;24:41–47. doi: 10.1080/02791072.1992.10471617. [DOI] [PubMed] [Google Scholar]
  • 15.Rich JD, Wolf FA, Macalino G. Strategies to improve access to sterile syringes for injection drug users. AIDS Read. 2002;12:527–535. [PubMed] [Google Scholar]
  • 16.Kerr T, Douglas D, Peeace W, Pierre A, Wood E. Responding to an Emergency: Education, Advocacy, and Community Care by a Peer-Driven Organization of Drug Users: A Case Study of the Vancouver Area Network of Drug Users (VANDU). Health Canada Hepatitis C Prevention, Support, and Research Program Report; 2001.
  • 17.Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1998;113(Suppl 1):151–159. [PMC free article] [PubMed] [Google Scholar]
  • 18.Friedman SR, Jong W, Wodak A. Community development as a response to HIV among drug injectors. AIDS. 1993;7(Suppl 1):S263–S269. doi: 10.1097/00002030-199301001-00037. [DOI] [PubMed] [Google Scholar]
  • 19.Canadian HIV/AIDS Legal Network press relase September 12, 2002. Canadian drug user organization receives prestigious human rights award. Available at: http://www.aidslaw.ca/Media/press-relases/e-press-sept1202 VANDU.pdf. Accessed January 7, 2003.
  • 20.Wood E, Tyndall MW, Spittal PM, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ. 2001;165:405–410. [PMC free article] [PubMed] [Google Scholar]
  • 21.Police thwart service to help addicts. Vancouver Sun. June 5, 2002:B1.
  • 22.Eurchuk R. Agency accused of misrepresenting study. Georgia Straight. 2002;27:11–11. [Google Scholar]
  • 23.Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health. 2002;79:257–265. doi: 10.1093/jurban/79.2.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wood E, Tyndall MW, Spittal PM, et al. Supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ. 2003;168:165–169. [PMC free article] [PubMed] [Google Scholar]
  • 25.Wood E, Kerr T, Spittal PM, Tyndall MW, O’Shaughnessy MV, Schechter MT. The healthcare and fiscal costs of the illicit drug use epidemic: the impact of conventional drug control strategies and the impact of a comprehensive approach. BC Med J. 2003;45:130–136. [Google Scholar]
  • 26.Albert T, Williams G, Remis R, Legowski B. Canadian Policy Research Network. The Economic Burden of HIV/AIDS in Canada. Ontario, Canada: Renouf Publishing; 1998. [Google Scholar]
  • 27.Schechter MT, Strathdee SA, Cornelisse PG, et al. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak. AIDS. 1999;13:F45–F51. doi: 10.1097/00002030-199904160-00002. [DOI] [PubMed] [Google Scholar]
  • 28.Tyndall MW, Currie S, Spittal PM, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887–893. doi: 10.1097/00002030-200304110-00014. [DOI] [PubMed] [Google Scholar]
  • 29.Wood E, Spittal PM, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. In press. [DOI] [PMC free article] [PubMed]
  • 30.Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ. 2002;166:894–899. [PMC free article] [PubMed] [Google Scholar]
  • 31.Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36:737–742. doi: 10.1053/jhep.2002.35065. [DOI] [PubMed] [Google Scholar]
  • 32.Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94:675–683. doi: 10.1046/j.1360-0443.1999.9456755.x. [DOI] [PubMed] [Google Scholar]
  • 33.Bailey I. Pickton accused in 4 more deaths: “This is now the largest serial killer investigation in Canadian history. National Post. 2002;3:A1–A1. [Google Scholar]
  • 34.Broadhead RS, Kerr TH, Grund JP, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues. 2002;32:329–355. [Google Scholar]
  • 35.Broadhead RS, Heckathorn DD, Grund JC, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS: preliminary results of a peer-driven intervention. J Drug Issues. 1995;25:531–564. [Google Scholar]
  • 36.O’Neill T. The addicts take over: Vancouverites say “harm reduction” is making the city’s drug infested Skid Road even worse. Report Newsmagazine. 2000;27:19–20. [Google Scholar]
  • 37.Wood E, Kerr T, Spittal PM, et al. The potential public health and community impacts of safer injecting facilities: evicence from a cohort of injection drug users. J Acquir Immune Defic Syndr. 2003;32:2–8. doi: 10.1097/00126334-200301010-00002. [DOI] [PubMed] [Google Scholar]
  • 38.Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657–61. doi: 10.1016/S0140-6736(98)07026-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES